CCM
NVO

Condor Capital Management’s Novo Nordisk NVO Stock Holding History

Condor Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-62,402
Closed -$4.31M – 191
2025
Q2 		$4.31M Buy
62,402
+1,728
+3% +$118K 0.37% 64
2025
Q1 		$4.21M Buy
60,674
+828
+1% +$68.4K 0.39% 61
2024
Q4 		$5.15M Buy
59,846
+37,365
+166% +$4.04M 0.45% 50
2024
Q3 		$2.68M Buy
22,481
+164
+0.7% +$21.9K 0.24% 89
2024
Q2 		$3.19M Sell
22,317
-128
-0.6% -$17K 0.3% 75
2024
Q1 		$2.88M Sell
22,445
-193
-0.9% -$23K 0.28% 82
2023
Q4 		$2.34M Sell
22,638
-176
-0.8% -$17.4K 0.25% 91
2023
Q3 		$2.07M Buy
22,814
+62
+0.3% +$5.46K 0.25% 85
2023
Q2 		$1.84M Sell
22,752
-206
-0.9% -$16.8K 0.22% 99
2023
Q1 		$1.83M Sell
22,958
-130
-0.6% -$9.22K 0.23% 97
2022
Q4 		$1.56M Buy
+23,088
New +$1.35M 0.2% 110

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Condor Capital Management's NVO Position: Q3 2025 in Review

Condor Capital Management sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 62,402 shares — an estimated $4.31M sold.

Condor Capital Management first reported a position in NVO in Q4 2022 and held it in 11 quarters. The position peaked at $5.15M in Q4 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Condor Capital Management reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Condor Capital Management sold 62,402 Novo Nordisk shares in Q3 2025, an estimated $4.31M.
  • Condor Capital Management first reported a position in Novo Nordisk in Q4 2022 and held it in 11 quarters.
  • Condor Capital Management's Novo Nordisk position peaked at $5.15M in Q4 2024.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Condor Capital Management's 13F filing for Q3 2025, filed 7 Nov 2025.